Ginkgo Bioworks Holdings, Inc.
NYSE · Healthcare · Biological Products, (No Diagnostic Substances) · Boston, MA
DNA chart
What traders are saying about $DNA
Latest postsGinkgo Bioworks Holdings, Inc. news
- Ginkgo Bioworks 3Q 2026: Revenue $27.71M, EPS ($0.64) — 10-Q Summary
TradingView ·
- Revenue falls at Ginkgo Bioworks (DNA), even as its Q3 continuing-operations loss narrows.
Stock Titan ·
- Ginkgo Bioworks: 3 Key Takeaways for Long-Term Investors
fool.com ·
- Ginkgo Bioworks Posts $27.7 Million in Q3 Revenue, Reaffirms 2026 Cash-Burn Outlook
www.tokenpost.com ·
- Ginkgo Bioworks Q3 Earnings Call Highlights
marketbeat.com ·
- Ginkgo Bioworks Holdings, Inc. (DNA) stock price, news, quote and history
Yahoo Finance Australia ·
- Ginkgo Bioworks Holdings, Inc. Q3 2026 Earnings Call Summary
app.moby.co ·
- Ginkgo Bioworks (DNA) Q3 2026 Earnings Call Transcript
fool.com ·
- Ginkgo Bioworks (DNA) Reports Q3 Revenue Growth Fueled by Novo N
GuruFocus ·
- Ginkgo Bioworks earnings beat by $0.37, revenue topped estimates
Investing.com Australia ·
- Ginkgo Bioworks Narrows Q3 Loss and Signs Novo Lab Deal
Securities.io ·
- Ginkgo Bioworks Holdings, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
Ginkgo Bioworks Holdings, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $170.2M | $227.0M | $251.5M | $477.7M |
| Net income | -$313,000 | -$547,000 | -$893,000 | -$2.1M |
| Diluted EPS | $-5.64 | $-10.54 | $-18.37 | $-50.20 |
| Total assets (year end) | $1.12B | $1.38B | $1.67B | $2.54B |
| Cash and equivalents (year end) | $167.2M | $561.6M | $944.1M | $1.32B |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Ginkgo Bioworks Holdings, Inc.
- Ticker
- DNA (NYSE)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1830214
- Former names
- Soaring Eagle Acquisition Corp., Spinning Eagle Acquisition Corp.
Frequently asked questions
What exchange is Ginkgo Bioworks Holdings, Inc. listed on?
Ginkgo Bioworks Holdings, Inc. trades on the NYSE under the ticker symbol DNA.
What industry is Ginkgo Bioworks Holdings, Inc. in?
Ginkgo Bioworks Holdings, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Ginkgo Bioworks Holdings, Inc. headquartered?
Ginkgo Bioworks Holdings, Inc.'s business address on file with the SEC is in Boston, MA.
When does Ginkgo Bioworks Holdings, Inc.'s fiscal year end?
Ginkgo Bioworks Holdings, Inc.'s fiscal year ends on December 31.
How much revenue did Ginkgo Bioworks Holdings, Inc. report?
Ginkgo Bioworks Holdings, Inc. reported $170.2M in revenue for calendar year 2025, according to its SEC filings.